Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Dosing Protocol Standard Research Protocol Dose: 300mcg per day subcutaneous Timing: Fasted ideally 3060 minutes before eating or exercise Injection site: Lower abdomen or thigh (standard subQ technique) Frequency: Daily, or 5 days on / 2 days off Cycle length: 812 weeks, then 46 week break Reconstitution AOD-9604 dissolves readily in bacteriostatic water (BAC water) no acetic acid required, unlike some hydrophobic peptides
People with autoimmune disorders (especially thyroid disorders such as Hashimotos thyroiditis and Graves disease) Type 1 diabetes, vitiligo, lupus, Addisons disease, ulcerative colitis, infertility, acquired agammaglobulinemia, or a family history of these disorders
Because of its potential to enhance metabolic efficiency and endurance, MOTS-c is on the WADA Prohibited List in category S4
Because plans are individual, we review the full cost, including the initial evaluation and any labs, before you begin, so there are no surprises
These spots tend to be less sensitive and make it easier for the medication to absorb gradually
Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004
US$ 28.42
US$ 25.86
US$ 21.68
